4SA logo

AcouSort DB:4SA Stock Report

Last Price

€0.88

Market Cap

€13.9m

7D

-7.0%

1Y

-35.1%

Updated

23 Dec, 2024

Data

Company Financials +

4SA Stock Overview

A technology company, develops products and solutions for automated preparation of biological samples based on acoustofluidics technology for researchers and life science companies. More details

4SA fundamental analysis
Snowflake Score
Valuation0/6
Future Growth2/6
Past Performance0/6
Financial Health4/6
Dividends0/6

My Notes

Capture your thoughts, links and company narrative

AcouSort AB (publ) Competitors

Price History & Performance

Summary of share price highs, lows and changes for AcouSort
Historical stock prices
Current Share PriceSEK 0.88
52 Week HighSEK 1.68
52 Week LowSEK 0.74
Beta0.72
1 Month Change-3.31%
3 Month Change-22.13%
1 Year Change-35.11%
3 Year Change-65.10%
5 Year Changen/a
Change since IPO-63.69%

Recent News & Updates

Recent updates

Shareholder Returns

4SADE BiotechsDE Market
7D-7.0%-3.5%-2.0%
1Y-35.1%-14.7%6.9%

Return vs Industry: 4SA underperformed the German Biotechs industry which returned -14.7% over the past year.

Return vs Market: 4SA underperformed the German Market which returned 6.9% over the past year.

Price Volatility

Is 4SA's price volatile compared to industry and market?
4SA volatility
4SA Average Weekly Movement11.2%
Biotechs Industry Average Movement6.8%
Market Average Movement4.9%
10% most volatile stocks in DE Market11.3%
10% least volatile stocks in DE Market2.4%

Stable Share Price: 4SA's share price has been volatile over the past 3 months compared to the German market.

Volatility Over Time: 4SA's weekly volatility (11%) has been stable over the past year, but is still higher than 75% of German stocks.

About the Company

FoundedEmployeesCEOWebsite
201017Torsten Freltoftwww.acousort.com

AcouSort AB (publ), a technology company, develops products and solutions for automated preparation of biological samples based on acoustofluidics technology for researchers and life science companies. It offers AcouTrap, a benchtop research instrument for sample preparation of cells, extracellular vesicles, bacteria, and viruses from various media; AcouPlasma, an integrated blood plasma separation module that enables in-line analysis of blood plasma from whole blood samples; and AcouWash, a benchtop research instrument for label-free separation of target cells from various samples. The company has collaboration agreement with global life science company to develop cell therapy.

AcouSort AB (publ) Fundamentals Summary

How do AcouSort's earnings and revenue compare to its market cap?
4SA fundamental statistics
Market cap€13.89m
Earnings (TTM)-€1.63m
Revenue (TTM)€697.77k

19.9x

P/S Ratio

-8.5x

P/E Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
4SA income statement (TTM)
RevenueSEK 8.03m
Cost of RevenueSEK 708.00k
Gross ProfitSEK 7.32m
Other ExpensesSEK 26.12m
Earnings-SEK 18.80m

Last Reported Earnings

Sep 30, 2024

Next Earnings Date

Feb 26, 2025

Earnings per share (EPS)-1.26
Gross Margin91.18%
Net Profit Margin-234.22%
Debt/Equity Ratio0%

How did 4SA perform over the long term?

See historical performance and comparison

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/23 12:37
End of Day Share Price 2024/12/20 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

AcouSort AB (publ) is covered by 1 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
John WestborgRedeye